Relation of HTLV-III seropositivity and lymphadenopathy.
Testing for antibody to human T-lymphotropic retrovirus (HTLV-III) was carried out in five groups of homosexual men: 250 without lymphadenopathy (control group), 37 with slight or nonpersistent lymph node enlargement (intermediate group), 141 with persistent generalized lymphadenopathy, 32 with persistent generalized lymphadenopathy who underwent biopsy and 11 in whom acquired immune deficiency syndrome (AIDS) was diagnosed. The rates of HTLV-III seropositivity in the five groups were 18%, 32%, 61%, 94% and 91% respectively.
Jeffries
E
E
Boyko
W J
WJ
Willoughby
B
B
Constance
P D
PD
Wiggs
B
B
O'Shaughnessy
M
M
Sharp
F R
FR
D000163:Acquired Immunodeficiency Syndrome / Q000276:immunology; D000914:Antibodies, Viral / Q000032:analysis*; D001955:British Columbia; D017977:Deltaretrovirus / Q000276:immunology*; D004797:Enzyme-Linked Immunosorbent Assay; D006716:Homosexuality; D006801:Humans; D008206:Lymphatic Diseases / Q000276:immunology*; D008297:Male; D011446:Prospective Studies
D000914:Antibodies, Viral